Patents Assigned to Altana Pharma, AG
  • Tricyclic benzimidazoles
    Publication number: 20070037840
    Abstract: The invention relates to 6,7,8,9-Tetrahydro-3H-imidazo[4,5-h]quinolines of formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Application
    Filed: December 16, 2004
    Publication date: February 15, 2007
    Applicant: Altana Pharma AG
    Inventor: Wilm Buhr
  • Pharmaceutical preparation comprising an active dispersed on a matrix
    Patent number: 7175854
    Abstract: The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohol, triglyceride, partial glyceride and fatty acid ester.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: February 13, 2007
    Assignee: Altana Pharma AG
    Inventors: Rango Dietrich, Rudolf Linder, Hartmut Ney
  • Surfactant protein C esters
    Patent number: 7173009
    Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
    Type: Grant
    Filed: November 28, 2005
    Date of Patent: February 6, 2007
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Ernst Sturm
  • Use of ciclesonide for the treatment of respiratory diseases
    Publication number: 20070025923
    Abstract: The invention relates to new method of treatment of respiratory diseases, in particular the treatment of asthmatic children.
    Type: Application
    Filed: September 15, 2004
    Publication date: February 1, 2007
    Applicant: Altana Pharma AG
    Inventors: Wilhelm Wurst, Thomas Bethke, Renate Engelstaetter
  • Use of known active ingredients as radical scavengers
    Publication number: 20070027189
    Abstract: The invention relates to the use of certain proton pump inhibitors in the treatment of pathological manifestations induced or influenced by free radicals.
    Type: Application
    Filed: September 17, 2004
    Publication date: February 1, 2007
    Applicant: Altana Pharma AG
    Inventors: Wolfgang-Alexander Simon, Ernst Strum
  • Compliance monitor and method
    Publication number: 20070023034
    Abstract: A compliance monitor (20) is attachable to or forms part of a drug delivery device, such as an inhaler (2). The monitor comprises a flexible portion (38) to enable a switch which is actuated by a user when delivering a dose of medicament. The monitor further comprises a sensor for sensing whether the device is properly positioned in contact with or relative to the user's body for administration of the medicament. For example, where the device is an inhaler and the sensor a temperature sensor, temperature variations caused by insertion of an inhaler mouthpiece into the user's mouth indicate whether the dose has been delivered into the patient's mouth. A memory in the compliance monitor stores a compliance record indicating whether or not the device was properly positioned each time a dose was delivered.
    Type: Application
    Filed: September 22, 2004
    Publication date: February 1, 2007
    Applicant: Altana Pharma AG
    Inventors: Robert Jongejan, Antje-Henriette Fink-Wagner, Christopher Ferris
  • Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
    Publication number: 20070010549
    Abstract: The compounds of formula (I) in which R1, R2, R3, R4 and R11 have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 30, 2004
    Publication date: January 11, 2007
    Applicant: Altana Pharma AG
    Inventor: Thomas Fuchss
  • Imidazopyridine-derivatives as inducible no-synthase inhibitors
    Publication number: 20060293302
    Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 30, 2004
    Publication date: December 28, 2006
    Applicant: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • Salmeterol and ciclesonide combination
    Publication number: 20060293293
    Abstract: The invention relates to pharmaceutical compositions containing combinations of salmeterol and ciclesonide and the use of such pharmaceutical compositions in medicine, in particular, the prophylaxis and treatment of respiratory disease.
    Type: Application
    Filed: May 19, 2004
    Publication date: December 28, 2006
    Applicant: Altana Pharma AG
    Inventors: Helgert Muller, Tushar Shah
  • Use of pde4 inhibitors for the treatment of diabetes mellitus
    Publication number: 20060281745
    Abstract: The invention relates to the use of certain known PIDE4 inhibitors for the treatment of diabetes mellitus and accompanying disorders thereof.
    Type: Application
    Filed: September 2, 2004
    Publication date: December 14, 2006
    Applicant: Altana Pharma AG
    Inventor: Hans-Peter Kley
  • Rapidly disintegrating tablet comprising an acid-labile active ingredient
    Patent number: 7147869
    Abstract: A rapidly disintegrating tablet for oral administration of acid-labile active ingredients is described. The rapidly disintegrating tablet for oral administration of an acid-labile active ingredient comprises a plurality of individual active ingredient units together with pharmaceutical excipients, where the acid-labile active ingredient is present in the individual active ingredient units in a matrix composed of a mixture comprising at least one solid paraffin and one or more substances from the group of fatty alcohol, triglyceride and fatty acid ester, and where excipients which, on oral intake of the tablet, bring about rapid disintegration of the tablet are present.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: December 12, 2006
    Assignee: Altana Pharma AG
    Inventors: Rango Dietrich, Hartmut Ney, Rudolf Linder
  • Imidazopyridine intermediates
    Publication number: 20060276499
    Abstract: The invention relates to compounds of the formula (I), in which the substituents and symbols have the meanings indicated in the description. The compounds are valuable intermediates for the preparation of pharmaceutical active compounds.
    Type: Application
    Filed: May 4, 2004
    Publication date: December 7, 2006
    Applicant: Altana Pharma AG
    Inventors: Christof Brehm, Wilm Buhr
  • Polysubstituted imidazopyridines as gastric secretion inhibitors
    Patent number: 7141567
    Abstract: The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: November 28, 2006
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr, Peter Zimmermann, Bernhard Kohl
  • Alkoxypyridine-derivatives
    Patent number: 7138399
    Abstract: The compounds of formula I in which R1 is 1–4C-alkoxy, A is 1–4C-alkylene, B represents 3H-imidazo[4,5-b]pyridin-2-yl, 3H-imidazo[4,5-b]pyridin-2-yl substituted by R2 and/or R3, 9H-purin-8-yl or 9H-purin-8-yl substituted by R4 and/or R5, are effective iNOS inhibitors.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: November 21, 2006
    Assignee: Altana Pharma AG
    Inventor: Wolf-Rüdiger Ulrich
  • Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
    Patent number: 7135452
    Abstract: Recombinant surfactant protein A and pharmaceutical compositions based thereon are useful for the prevention or treatment of pulmonary infection and inflammation.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: November 14, 2006
    Assignee: Altana Pharma AG
    Inventors: Wolfram Steinhilber, Jeffrey A. Whitsett, Ann Marie Levine, Thomas R. Korfhagen
  • Dosage form containing pantoprazole as active ingredient
    Publication number: 20060240100
    Abstract: Dosage forms for the oral administration of the magnesium salt of pantoprazole are described.
    Type: Application
    Filed: May 7, 2004
    Publication date: October 26, 2006
    Applicant: Altana Pharma AG
    Inventor: Isabel Anstett
  • Novel intermediate for the preparation of therapeutically active imidazopyridines
    Publication number: 20060235228
    Abstract: The invention relates to the 1,5-naphthalene disulfonic acid addition salt of the compound of the formula 1, or a solvate or hydrate thereof. The compound according to the invention is a valuable intermediate for the preparation of therapeutically active compounds.
    Type: Application
    Filed: May 13, 2004
    Publication date: October 19, 2006
    Applicant: Altana Pharma AG
    Inventors: Peter Zimmermann, Christian Scheufler, Bernhard Kohl
  • Use of ciclesonide for the treatment of inflammatory bowel diseases
    Publication number: 20060211668
    Abstract: The invention relates to the novel use of ciclesonide in the treatment of inflammatory bowel disease.
    Type: Application
    Filed: September 15, 2004
    Publication date: September 21, 2006
    Applicant: ALTANA PHARMA AG
    Inventors: Florian Abel, Antje Brueck, Klaus Dietzel, Klaus Eistetter, Ruediger Nave, Stefan Postius, Oliver Von Richter
  • Tetrahydropyridoethers
    Patent number: 7105676
    Abstract: Compounds of formula (1) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: September 12, 2006
    Assignee: Altana Pharma AG
    Inventor: Jörg Senn-Bilfinger
  • Tryptase inhibitors
    Patent number: 7101911
    Abstract: Compounds of the formula I, in which M, A1, A2, K1 and K2 have the meanings given in the description are novel effective tryptase inhibitors.
    Type: Grant
    Filed: February 16, 2002
    Date of Patent: September 5, 2006
    Assignee: Altana Pharma AG
    Inventor: Thomas Martin